Mirum Pharmaceuticals, Inc.

MIRM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$3-$6-$15-$24
Dep. & Amort.$6$6$6$6
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$18$16$13
Change in WC$12-$7-$11-$2
Other Non-Cash$19-$0$2$1
Operating Cash Flow$40$12-$2-$5
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$21-$32-$34-$11
Inv. Sales/Matur.$19$25$17$12
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2-$7-$16$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$16$9$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$6$5
Financing Cash Flow$16$9$6$5
Forex Effect$0$2$1-$1
Net Chg. in Cash$54$16-$11-$0
Supplemental Information
Beg. Cash$228$212$223$223
End Cash$282$229$212$223
Free Cash Flow$39$12-$2-$5
Mirum Pharmaceuticals, Inc. (MIRM) Financial Statements & Key Stats | AlphaPilot